Manchikanti, Laxmaiah;
Kaye, Adam M;
Knezevic, Nebojsa Nick;
Giordano, James;
Applewhite, Megan K;
Bautista, Alexander;
Soin, Amol;
Blank, Susan K;
Sanapati, Mahendra R;
Karri, Jay;
Christo, Paul J;
Abd-Elsayed, Alaa;
Kaye, Alan D;
Calodney, Aaron;
Navani, Annu;
Gharibo, Christopher G;
Harned, Michael;
Gupta, Mayank;
Broachwala, Mustafa;
Sehgal, Nalini;
Kaufman, Andrew;
Wargo, Bradley;
Solanki, Daneshvari R;
Hsu, Eric S;
Limerick, Gerard;
Dennis, Allen;
Swicegood, John R;
Slavin, Konstantin;
Snook, Lee;
Pasupuleti, Ramarao;
Kosanovic, Radomir;
Justiz, Rafael;
Barkin, Robert;
Atluri, Sairam;
Shah, Shalini;
Pampati, Vidyasagar;
Helm II, Standiford;
Grami, Vahid;
Myckowiak, Vicki;
Galan, Vincent;
Singh, Vijay;
Manocha, Vivek;
Hirsch, Joshua A.
Opioid prescribing in the United States is decreasing, however, the opioid epidemic
is continuing at an uncontrollable rate. Available data show a significant number of opioid deaths,
primarily associated with illicit fentanyl use. It is interesting to also note that the data show no
clear correlation be...
This guideline covers targeted interventions to prevent misuse of drugs, including illegal drugs, ‘legal highs’ and prescription-only medicines. It aims to prevent or delay harmful use of drugs in children, young people and adults who are most likely to start using drugs or who are already experiment...
In 2015 WHO updated the mhGAP guidelines, first issued in 2009, for the management of mental, neurological and substance use (MNS) disorders. In order to reduce the gap and to enhance the capacity of Member States to respond to the growing challenge, the World Health Organization (WHO) developed the Ment...
These guidelines contain recommendations on the identification and management of substance use and substance use disorders for health care services which assist women who are pregnant, or have recently had a child, and who use alcohol or drugs or who have a substance use disorder. They have been develope...
This guideline covers assessing and managing people aged 14 years and over with coexisting severe mental illness (psychosis) and substance misuse. It aims to help healthcare professionals guide people with psychosis with coexisting substance misuse to stabilise, reduce or stop their substance misuse, to ...
